Is ArriVent BioPharma, Inc. (AVBP) a Buy, Sell, or Hold?
NASDAQ : AVBP
ArriVent BioPharma, Inc. — Competitors
$29.7347 USD
-$0.43 (-1.41%)
- Volume
- 617.68K
- Average Volume
- 550.8K
- Market Capitalization
- $1.38B
- P/E Ratio
- -8.43
- Dividend Yield
- 0.00%
- Price Target
- $45.00
- Year High
- $35.83
- Year Low
- $16.10
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.95
AVBP vs. The Competition
| Properties | AVBP | ARVN | ATXS | DAWN |
|---|---|---|---|---|
| Market Cap | $1.39B | $527.46M | $718.13M | $2.22B |
| Shares Outstanding | $46.57M | $64.52M | $57.08M | $103.33M |
| P/E Ratio | -8.43 | -2.51 | -7.4 | -20.7 |
| EPS | -3.22 | -3.46 | -1.7 | -1.04 |
| Day Low | 29.3 | 8.03 | 12.58 | 21.53 |
| Day High | 31.12 | 8.32 | 12.58 | 21.53 |
| Year Low | 16.1 | 6.06 | 3.555 | 5.635 |
| Year High | 35.83 | 14.51 | 13.29 | 21.53 |
| Average Price 50 | 31.0467 | 8.1914 | 12.7446 | 18.2116 |
| Average Price 200 | 25.1371 | 10.67015 | 8.31845 | 10.72363 |
| Volume | 617.68K | 325.75K | 3.06M | - |
| Average Volume | - | - | - | - |